Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1988]

Targeted combination therapy with potential to eliminate relapsed chronic...

Dr Andrew Roberts - Royal Melbourne Hospital, Melbourne, Australia

Targeted combination therapy with potential to eliminate relapsed chronic lymphocytic leukaemia ( Dr Andrew Roberts - Royal Melbourne Hospital, Melbourne, Australia )

DNMT3A R882 mutations promote chemoresistance and residual disease in AML

Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA

DNMT3A R882 mutations promote chemoresistance and residual disease in AML ( Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA )

New targeted combination therapy with potential to eliminate relapsed chronic...

Dr Andrew Roberts - Royal Melbourne Hospital, Melbourne, Australia

New targeted combination therapy with potential to eliminate relapsed chronic lymphocytic leukaemia ( Dr Andrew Roberts - Royal Melbourne Hospital, Melbourne, Australia )

First randomised evidence for kinase inhibitor activity in acute myeloid...

Dr Gerhard Ehninger - University Hospital Dresden, Dresden, Germany

First randomised evidence for kinase inhibitor activity in acute myeloid leukaemia ( Dr Gerhard Ehninger - University Hospital Dresden, Dresden, Germany )

Does the patient with myelofibrosis feel better through pacritinib?

Dr Ruben Mesa - Mayo Clinic Cancer Center, Scottsdale, USA

Does the patient with myelofibrosis feel better through pacritinib? ( Dr Ruben Mesa - Mayo Clinic Cancer Center, Scottsdale, USA )

Adding elotuzumab to standard treatment for multiple myeloma significantly...

Dr Meletios Dimopoulos - National and Kapodistrian University of Athens, Athens...

Adding elotuzumab to standard treatment for multiple myeloma significantly reduced the risk of disease progression ( Dr Meletios Dimopoulos - National and Kapodistrian University of Athens, Athens, Greece )

Treatment and survival of patients with chronic myeloid leukaemia in Europe

Dr Verena Hoffmann - Ludwig-Maximilians-Universität, München, Germany

Treatment and survival of patients with chronic myeloid leukaemia in Europe ( Dr Verena Hoffmann - Ludwig-Maximilians-Universität, München, Germany )

Expert overview on the recent developments in mantle cell lymphoma

Professor Gordon McVie and Professor Simon Rule

Expert overview on the recent developments in mantle cell lymphoma ( Professor Gordon McVie and Professor Simon Rule )

New dexamethasone combination yields two-fold improvement in median PFS in...

Prof Meletios Dimopoulos - University of Athens, Athens, Greece

New dexamethasone combination yields two-fold improvement in median PFS in multiple myeloma ( Prof Meletios Dimopoulos - University of Athens, Athens, Greece )

ASCO 2015: Latest developments in multiple myeloma

Prof Philippe Moreau, Prof Sagar Lonial, Prof Meletios Dimopoulos

ASCO 2015: Latest developments in multiple myeloma ( Prof Philippe Moreau, Prof Sagar Lonial, Prof Meletios Dimopoulos )

ASCO 2015: Latest in chronic lymphocytic leukaemia

Prof Stephan Stilgenbauer and Dr Jacqueline Barrientos

ASCO 2015: Latest in chronic lymphocytic leukaemia ( Prof Stephan Stilgenbauer and Dr Jacqueline Barrientos )

Dasatinib plus intensive chemo versus stem cell transplant for Philadelphia...

Dr William Slayton - University of Florida, Gainsville, USA

Dasatinib plus intensive chemo versus stem cell transplant for Philadelphia chromosome positive ALL ( Dr William Slayton - University of Florida, Gainsville, USA )

More from ecancer